Brief: China Resources Pharmaceutical Says Total Operating Income Of Jiangzhong Pharmaceutical For 9 Mths Expected To Increase By 45%
17/10/2022 01:38
Oct 17 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* TOTAL OPERATING INCOME OF JIANGZHONG PHARMACEUTICAL FOR 9
MONTHS
EXPECTED TO INCREASE BY ABOUT 45% Y-O-Y
* NET PROFIT ATTRIBUTABLE OF JIANGZHONG PHARMACEUTICAL
EXPECTED TO
INCREASE BY ABOUT 12% Y-O-Y FOR 9 MONTHS
Source text for Eikon: ID:nHKS6kGndK
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million